LOGIN  |  REGISTER
Amneal Pharmaceuticals

Recent Insider Transactions - Bicara Therapeutics (NASDAQ: BCAX)

Follow NASDAQ:BCAX Visit website
Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NASDAQ BCAX Bicara Therapeutics
Meisner Lara / officer: Chief Legal Officer
06/16/2025
Sell
$5.45
9,744
$53K
97,443
NASDAQ BCAX Bicara Therapeutics
Meisner Lara / officer: Chief Legal Officer
06/16/2025
Sell
$5.45
6,085
$33K
60,854
NASDAQ BCAX Bicara Therapeutics
Meisner Lara / officer: Chief Legal Officer
06/16/2025
Buy
$5.45
15,829
$86K
15,829
NASDAQ BCAX Bicara Therapeutics
Meisner Lara / officer: Chief Legal Officer
06/16/2025
Sell
$10.43
15,829
$165K
0
NASDAQ BCAX Bicara Therapeutics
Haviland Kate / director
06/09/2025
Buy
$11.48
23,746
$273K
23,746
NASDAQ BCAX Bicara Therapeutics
RA CAPITAL MANAGEMENT, L.P. / director, 10 percent owner:
06/09/2025
Buy
$11.48
23,746
$273K
23,746
NASDAQ BCAX Bicara Therapeutics
Mazumdar-Shaw Kiran / director, 10 percent owner:
06/09/2025
Buy
$11.48
23,746
$273K
23,746
NASDAQ BCAX Bicara Therapeutics
POWELL MICHAEL / director
06/09/2025
Buy
$11.48
23,746
$273K
23,746
NASDAQ BCAX Bicara Therapeutics
LONBERG NILS / director
06/09/2025
Buy
$11.48
23,746
$273K
23,746
NASDAQ BCAX Bicara Therapeutics
Robertson Scott M. / director
06/09/2025
Buy
$11.48
23,746
$273K
23,746
NASDAQ BCAX Bicara Therapeutics
Simson Jake / director
06/09/2025
Buy
$11.48
23,746
$273K
23,746
NASDAQ BCAX Bicara Therapeutics
Bowden Christopher / director
06/09/2025
Buy
$11.48
23,746
$273K
23,746

  Research Tools
  News & Announcements
  Popular Topics
  Miscellaneous